Paper17547502
Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.
Gin A and 5 others. Expert Rev Anti Infect Ther, 2007. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. Papers, record 17547502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547502
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| beta-Lactamase Inhibitors | Major topic |
| Clinical Trials as Topic | |
| Drug Resistance, Bacterial | |
| Humans | |
| Microbial Sensitivity Tests | |
| Neutropenia | |
| Penicillanic Acid | |
| Piperacillin | |
| Piperacillin, Tazobactam Drug Combination | |
| Pneumonia, Bacterial | |
| Randomized Controlled Trials as Topic | |
| Soft Tissue Infections |
Source PubMed
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42989114 | Effects of common antibiotics on representative gut bacterial strains associated with inflammatory bowel disease. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42989114 | PubMed |
| 42592029 | Anaphylactic Shock Probably due to a Cross-Reaction Between Cefuroxime and Piperacillin-Presentation of a Fatal Case, Diagnostic Considerations, and Literature Review. | Case Rep Crit Care | 2026 | https://conductscience.org/library/papers/42592029 | PubMed |
| 42556984 | Antibiotic Therapy for the Prevention and Treatment of Neonatal Sepsis. | Clin Perinatol | 2026 | https://conductscience.org/library/papers/42556984 | PubMed |
| 42477084 | Comparative analysis of cefoperazone-sulbactam and piperacillin-tazobactam in empirical treatment of acute biliary tract infections: a multicenter, retrospective, real-world study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42477084 | PubMed |
| 42256409 | Thrombocytopenia and anemia associated with piperacillin-tazobactam: integrating clinical case series with FAERS disproportionality analysis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42256409 | PubMed |
| 42112094 | Optimal Piperacillin/Tazobactam Dosing in Adults with Low Body Weight: A Population Pharmacokinetic and Simulation-Based Study. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42112094 | PubMed |
| 41889519 | Piperacillin-tazobactam-associated thrombocytopenia with negative antiplatelet antibody testing: a case report and literature review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41889519 | PubMed |
| 41715151 | Evaluation of piperacillin-tazobactam appropriateness and underlying drivers of inappropriate prescribing in a Belgian University Hospital: a retrospective study. | Antimicrob Resist Infect Control | 2026 | https://conductscience.org/library/papers/41715151 | PubMed |
| 40823816 | Piperacillin reaches high concentrations in bile and target tissues of the biliary system: an experimental study in pigs. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40823816 | PubMed |
| 40657038 | Unfolding the collective functional potential of a synergistic multispecies community through genotypic and phenotypic analyses. | Biofilm | 2025 | https://conductscience.org/library/papers/40657038 | PubMed |
| 40504338 | Antibiotic-related dysbiosis of gut microbiota in healthy volunteers: a comparative study of ceftazidime-avibactam, piperacillin-tazobactam, and ceftriaxone. | Eur J Clin Microbiol Infect Dis | 2025 | https://conductscience.org/library/papers/40504338 | PubMed |
| 40212240 | Ionizable Lipid Containing Nanocarriers for Antimicrobial Agent Delivery. | Small Sci | 2024 | https://conductscience.org/library/papers/40212240 | PubMed |
| 39722108 | A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the Elderly. | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/39722108 | PubMed |
| 39695560 | Antibiotics versus Non-Antibiotic in the treatment of Aspiration Pneumonia: analysis of the MIMIC-IV database. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/39695560 | PubMed |
| 39635712 | A pharmaceutical policy accident: collision of shareholder capitalism and Chinese state capitalism driving the shortage of an essential antibiotic. | J Pharm Policy Pract | 2024 | https://conductscience.org/library/papers/39635712 | PubMed |
| 39501680 | Fungal dysbiosis following antibacterial monotherapy in canine otitis externa. | J Small Anim Pract | 2025 | https://conductscience.org/library/papers/39501680 | PubMed |
| 39248479 | Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/39248479 | PubMed |
| 39107511 | An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study. | Sci Rep | 2024 | https://conductscience.org/library/papers/39107511 | PubMed |
| 39081458 | Extended Spectrum beta-Lactamase Bacteria and Multidrug Resistance in Jordan are Predicted Using a New Machine-Learning system. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/39081458 | PubMed |
| 38391033 | Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review). | Int J Oncol | 2024 | https://conductscience.org/library/papers/38391033 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17547502
GET https://conductscience.org/api/papers/v1/17547502/cited_by?page=2